recall
saveAscend Laboratories, LLC recall (Cls II)
June 18, 2025updated 5mo ago
community read0 votes
Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascent Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-544-68 — Reason: Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct. — Status: Ongoing
view source ↗Data sources
last refreshed 37m ago
Found something off?
same company · ±60 days · 3
🐶 often sniffed alongside
top 8- tagRecall22 co-mentions · 12 sources
- companyAlkem Laboratories Ltd20 co-mentions · 11 sources
- drugatorvastatin calcium8 co-mentions · 4 sources
- drugatorvastatin8 co-mentions · 4 sources
- drugLipitor8 co-mentions · 4 sources
- drugrizatriptan benzoate4 co-mentions · 2 sources
- drugcephalexin4 co-mentions · 2 sources
- drugrizatriptan benzoate ODT4 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that